FF-10101-01 is under investigation in clinical trial NCT03194685 (Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.